Finch Therapeutics Group Price History

FNCHDelisted Stock  USD 8.51  0.19  2.18%   
If you're considering investing in Finch Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Finch Therapeutics stands at 8.51, as last reported on the 4th of January, with the highest price reaching 8.80 and the lowest price hitting 8.51 during the day. We have found twenty-three technical indicators for Finch Therapeutics Group, which you can use to evaluate the volatility of the firm. Please confirm Finch Therapeutics' Standard Deviation of 7.46, variance of 55.65, and Mean Deviation of 4.29 to check if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Finch Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
FNCH
Based on monthly moving average Finch Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Finch Therapeutics by adding Finch Therapeutics to a well-diversified portfolio.

Finch Therapeutics Pink Sheet Price History Chart

There are several ways to analyze Finch Stock price data. The simplest method is using a basic Finch candlestick price chart, which shows Finch Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Finch Pink Sheet Price History Data

The price series of Finch Therapeutics for the period between Sun, Oct 6, 2024 and Sat, Jan 4, 2025 has a statistical range of 6.83 with a coefficient of variation of 18.05. Under current investment horizon, the daily prices are spread out with arithmetic mean of 9.79. The median price for the last 90 days is 8.99. The company completed 1:30 stock split on 12th of June 2023.
OpenHighLowCloseVolume
01/04/2025
 8.70  8.80  8.51  8.51 
07/24/2023 8.70  8.80  8.51  8.51  1,982 
07/21/2023 8.98  9.00  8.76  8.95  5,433 
07/20/2023 9.01  9.48  8.80  8.80  6,288 
07/19/2023 9.04  9.29  8.95  9.05  4,618 
07/18/2023 9.09  9.24  8.84  8.91  8,473 
07/17/2023 9.16  9.47  9.06  9.22  6,903 
07/14/2023 9.04  9.40  8.80  9.17  20,321 
07/13/2023 9.05  9.34  8.94  9.00  10,587 
07/12/2023 9.34  9.34  8.86  8.92  2,048 
07/11/2023 9.27  9.42  8.84  9.29  45,845 
07/10/2023 9.06  9.38  9.02  9.29  15,833 
07/07/2023 8.54  9.30  8.54  9.25  13,068 
07/06/2023 8.75  9.07  8.61  9.04  2,037 
07/05/2023 9.04  9.26  8.61  9.13  9,394 
07/03/2023 8.91  9.17  8.60  8.77  10,476 
06/30/2023 8.53  9.00  8.53  8.53  5,237 
06/29/2023 8.37  8.65  8.23  8.38  8,179 
06/28/2023 7.94  8.23  7.93  8.22  10,476 
06/27/2023 7.88  8.18  7.87  7.89  8,846 
06/26/2023 8.02  8.31  7.87  7.87  14,640 
06/23/2023 8.29  8.31  8.08  8.08  21,965 
06/22/2023 8.37  8.70  8.36  8.44  13,278 
06/21/2023 8.25  9.35  7.36  8.37  152,708 
06/20/2023 8.23  8.43  8.05  8.40  7,731 
06/16/2023 8.50  8.71  8.21  8.26  20,169 
06/15/2023 8.61  8.65  8.03  8.65  38,830 
06/14/2023 8.67  9.25  8.40  8.66  82,303 
06/13/2023 8.86  9.05  8.16  8.83  264,492 
06/12/2023 8.09  16.74  7.75  11.50  1,025,734 
06/09/2023 8.10  8.55  7.81  8.13  17,968 
06/08/2023 8.46  8.56  8.13  8.55  3,649 
06/07/2023 8.61  8.70  8.33  8.52  2,859 
06/06/2023 0.27  8.56  8.56  8.56  870.00 
06/05/2023 9.15  9.15  8.15  8.70  4,731 
06/02/2023 0.29  8.99  8.99  8.99  1,368 
06/01/2023 0.29  8.64  8.64  8.64  978.00 
05/31/2023 0.26  8.40  8.40  8.40  617.00 
05/30/2023 0.26  8.64  8.64  8.64  1,773 
05/26/2023 0.27  8.28  8.28  8.28  939.00 
05/25/2023 0.29  8.53  8.53  8.53  5,535 
05/24/2023 0.26  8.70  8.70  8.70  5,595 
05/23/2023 0.28  8.10  8.10  8.10  16,670 
05/22/2023 0.30  8.57  8.57  8.57  13,034 
05/19/2023 0.33  8.85  8.85  8.85  11,332 
05/18/2023 0.34  9.63  9.63  9.63  2,552 
05/17/2023 0.34  10.20  10.20  10.20  2,434 
05/16/2023 0.36  10.47  10.47  10.47  3,680 
05/15/2023 0.35  10.85  10.85  10.85  1,426 
05/12/2023 0.38  10.73  10.73  10.73  1,905 
05/11/2023 0.37  11.25  11.25  11.25  1,067 
05/10/2023 0.39  11.85  11.85  11.85  1,605 
05/09/2023 0.39  12.60  12.60  12.60  8,108 
05/08/2023 0.37  11.85  11.85  11.85  8,388 
05/05/2023 0.36  11.63  11.63  11.63  3,574 
05/04/2023 0.37  10.96  10.96  10.96  2,609 
05/03/2023 0.38  10.96  10.96  10.96  7,680 
05/02/2023 0.38  11.69  11.69  11.69  1,660 
05/01/2023 0.40  12.30  12.30  12.30  4,755 
04/28/2023 0.46  12.10  12.10  12.10  6,203 
04/27/2023 0.48  13.77  13.77  13.77  4,435 

About Finch Therapeutics Pink Sheet history

Finch Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Finch is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Finch Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Finch Therapeutics stock prices may prove useful in developing a viable investing in Finch Therapeutics
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. Finch Therapeutics Group, Inc. was incorporated in 2014 and is based in Somerville, Massachusetts. Finch Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 189 people.

Finch Therapeutics Pink Sheet Technical Analysis

Finch Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
A focus of Finch Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Finch Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Portfolio File Import Now

   

Portfolio File Import

Quickly import all of your third-party portfolios from your local drive in csv format
All  Next Launch Module

Finch Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Finch Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Finch Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Finch to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Consideration for investing in Finch Pink Sheet

If you are still planning to invest in Finch Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Finch Therapeutics' history and understand the potential risks before investing.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.